Literature DB >> 3019413

The role of apolipoproteins of HDL in the selective uptake of cholesteryl linoleyl ether by cultured rat and bovine adrenal cells.

E Leitersdorf, A Israeli, O Stein, S Eisenberg, Y Stein.   

Abstract

Rat adrenal cells in culture were used to study the uptake of cholesteryl linoleyl ether [( 3H]cholesteryl linoleyl ether), a nonhydrolyzable analog of cholesteryl ester. When [3H]cholesteryl linoleyl ether was added in the form of liposomes, its uptake was enhanced by adrenocorticotropin (ACTH) and by addition of milk lipoprotein lipase and interfered by heparin. When the adrenal cells were incubated with homologous [3H]cholesteryl linoleyl ether-HDL, ACTH treatment also resulted in an increase in [3H]cholesteryl linoleyl ether uptake. The uptake of [3H]cholesteryl linoleyl ether was in excess of the uptake and metabolism of 125I-labeled HDL protein and was not sensitive to heparin. Unlabeled HDL or delipidated HDL reduced very markedly the uptake of [3H]cholesteryl linoleyl ether, while addition of phosphatidylcholine liposomes had little effect. Attempts were made to deplete and enrich the adrenal cells in cholesterol and, while depletion resulted in a decrease in [3H]cholesteryl linoleyl ether-HDL uptake, enrichment of cells with cholesterol had no effect. Among the individual apolipoproteins tested, apolipoprotein A-I and the C apolipoproteins reduced [3H]cholesteryl linoleyl ether uptake, while apolipoprotein E was not effective. Since the labeled ligand studied was a lipid, these effects could not be due to an exchange of apolipoproteins, but indicated competition for binding sites. Preferential uptake of human [3H]cholesteryl linoleyl ether-HDL3 by bovine adrenal cells was found when compared to the uptake and metabolism of 125I-labeled HDL. The present results suggest that the preferential uptake of HDL cholesteryl ester (as studied with [3H]cholesteryl linoleyl ether) requires an interaction between the apolipoproteins of HDL and cell surface components.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019413     DOI: 10.1016/0005-2760(86)90239-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice.

Authors:  O Stein; Y Dabach; G Hollander; M Ben-Naim; G Halperin; J L Breslow; Y Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Metabolic fate of sphingomyelin of high-density lipoprotein in rat plasma.

Authors:  M Bentejac; M Bugaut; M C Delachambre; J Lecerf
Journal:  Lipids       Date:  1990-10       Impact factor: 1.880

Review 3.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

Review 4.  Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

Authors:  Wen-Jun Shen; Shailendra Asthana; Fredric B Kraemer; Salman Azhar
Journal:  J Lipid Res       Date:  2018-05-02       Impact factor: 5.922

5.  Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production.

Authors:  A S Plump; S K Erickson; W Weng; J S Partin; J L Breslow; D L Williams
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

6.  Greater selective uptake by Hep G2 cells of high-density lipoprotein cholesteryl ester hydroperoxides than of unoxidized cholesteryl esters.

Authors:  W Sattler; R Stocker
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

7.  Selective uptake of cholesteryl esters from apolipoprotein-E-free high-density lipoproteins by rat parenchymal cells in vivo is efficiently coupled to bile acid synthesis.

Authors:  M N Pieters; D Schouten; H F Bakkeren; B Esbach; A Brouwer; D L Knook; T J van Berkel
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.